Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study.

ABSTRACT:

Background

Providing patients with cancer who are undergoing systemic therapy with useful information about symptom management is essential to prevent unnecessary deterioration of quality of life.

Objective

The aim was to evaluate whether use of an app for symptom management was associated with any change in patient quality of life or use of health resources.

Methods

Outpatients with early stage breast cancer receiving systemic therapy were recruited at the Institute of Oncology in Ljubljana, Slovenia. Patients who received systemic therapy between December 2017 and March 2018 (control group) and between April 2018 and September 2018 (intervention group) were eligible. All patients received standard care, but only those in the intervention group were asked to use mPRO

SUBMITTER: Grasic Kuhar C 

PROVIDER: S-EPMC7435681 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature